NIM
SLNO

NEOS Investment Management’s Soleno Therapeutics SLNO Stock Holding History

NEOS Investment Management’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,033
Closed -$709K – 607
2024
Q3 		$709K Buy
14,033
+1,083
+8% +$51.8K 0.02% 440
2024
Q2 		$528K Buy
+12,950
New +$549K 0.02% 438

Other funds holding SLNO

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

NEOS Investment Management's SLNO Position: Q4 2024 in Review

NEOS Investment Management sold out of Soleno Therapeutics (SLNO) in Q4 2024, closing a stake of 14,033 shares — an estimated $709K sold.

NEOS Investment Management first reported a position in SLNO in Q2 2024 and held it in 2 quarters. The position peaked at $709K in Q3 2024. 166 funds tracked by Wall St. Rank hold SLNO as of Q4 2024.

  • NEOS Investment Management reported no remaining Soleno Therapeutics position as of Q4 2024 after selling out during the quarter.
  • NEOS Investment Management sold 14,033 Soleno Therapeutics shares in Q4 2024, an estimated $709K.
  • NEOS Investment Management first reported a position in Soleno Therapeutics in Q2 2024 and held it in 2 quarters.
  • NEOS Investment Management's Soleno Therapeutics position peaked at $709K in Q3 2024.
  • 166 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q4 2024.

Based on NEOS Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.